Received: 21 December 2021
Accepted: 26 September 2022
First Online: 8 November 2022
: The study has been approved by Shanghai Proton and Heavy Ion Center (SPHIC) Institutional Review Board and the number is 2006-62-03. It is conducted in accordance with the principles of the Declaration of Helsinki and the principles of Good Clinical Practice (ICH-GCP E6). All patients have written informed consent before inclusion in the trial.
: Not applicable.
: The authors declare that they have no competing interests.